Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Resverlogix (RFS) Stock Price & Analysis

RFS Stock Chart & Stats

€0.04€0.00(7.32%)
At close: 5:30 PM GMT+1
EUR 0.1EUR 0.223 Aug4 Apr11 Jul26 Jan23 Jul28 Jan20 Oct
Day’s Range
EUR 0.04 - EUR 0.04
52-Week Range
EUR 0.04 - EUR 0.09
Previous Close
EUR 0.04
Volume
0
Average Volume (3M)
1,333
Market Cap
EUR 16.49M
Enterprise Value
EUR 139.82M
Total Cash (Recent Filing)
EUR 79.87K
Total Debt (Recent Filing)
EUR 77.62M
Price to Earnings (P/E)
―
Beta
0.11
Next Earnings
Nov 06, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Focused Therapeutic Platform

A concentrated focus on BET proteins and epigenetic mechanisms gives Resverlogix a defined scientific platform rather than a broad, unfocused pipeline. If development succeeds, this specialization could support differentiated applications across cardiovascular and metabolic diseases over the medium term.

Intellectual Property And Licensing Orientation

An operating model centered on clinical development and intellectual property can preserve strategic commercialization options, including partnerships or licensing. Those routes may allow a small biotechnology company to pursue product value without building a full commercial infrastructure internally.

Cash Burn Not At Historical Peak

Although cash generation remains negative, the current burn rate is described as less severe than in at least one earlier period. This provides a limited operational offset because it suggests spending has not consistently accelerated, potentially extending planning flexibility if disciplined spending continues.

Bears Say

No Revenue And Persistent Losses

The absence of revenue alongside recurring operating and net losses leaves Resverlogix without an established commercial engine to fund research or corporate costs. Worsening TTM losses versus 2025 increase dependence on external capital and reduce visibility into a sustainable earnings path.

Structural Cash Consumption

Persistently negative operating and free cash flow means the business is consuming capital rather than internally financing development. Continued cash burn can force additional funding decisions, constrain research flexibility, and increase the importance of securing financing or commercial support.

Highly Stressed Capital Structure

Negative equity and debt that greatly exceeds the asset base indicate severe balance-sheet strain and limited financial flexibility. This structure raises solvency, refinancing, and dilution risks, potentially diverting resources from development and weakening the company’s negotiating position.

Resverlogix News

RFS FAQ

What was Resverlogix’s price range in the past 12 months?
Resverlogix lowest stock price was €0.04 and its highest was €0.09 in the past 12 months.
What is Resverlogix’s market cap?
Resverlogix’s market cap is €16.49M.
When is Resverlogix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Resverlogix’s earnings last quarter?
Resverlogix released its earnings results on Aug 14, 2026. The company reported -€0.016 earnings per share for the quarter.
Is Resverlogix overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Resverlogix pay dividends?
Resverlogix does not currently pay dividends.
What is Resverlogix’s EPS estimate?
Resverlogix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Resverlogix have?
Resverlogix has 344,286,700 shares outstanding.
What happened to Resverlogix’s price movement after its last earnings report?
Resverlogix reported an EPS of -€0.016 in its last earnings report. Following the earnings report the stock price went up 3.571%.
Which hedge fund is a major shareholder of Resverlogix?
Currently, no hedge funds are holding shares in DE:RFS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology